New Blood Test Could Diagnose Early Alzheimer’s

The test would be quick and easy to administer, as well as relatively inexpensive.

Researchers at Otago University in New Zealand believe a simple blood test could become the new way to diagnose early Alzheimer’s disease.

The website, News Ghana, reported that researchers at the university found that the specific set of blood microRNA could detect Alzheimer’s disease correctly 86% of the time.

“We know that the levels of these microRNA differ in people who have Alzheimer’s and people who don’t," said Dr. Joanna Williams, one of the researchers. "So if a GP took a blood sample from a patient who was beginning to show symptoms of memory loss, what we’d do is analyze that blood and see how that patient’s pattern of microRNA compares against established patterns."

The test, according to the article, would be "quick and easy to administer, relatively inexpensive and readily available."

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026
Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground